14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
LABD vs YANG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
YANG Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)
YANG Overall Winner
6-Pillar Tally: LABD 0 – 0 YANG (6 Tie)
Matrix Metrics: LABD 1 – 2 YANG
As of Nov 16, 2026, Direxion Daily FTSE China Bear 3X Shares (YANG) is the stronger overall head-to-head candidate over Direxion Daily S&P Biotech Bear 3X Shares (LABD) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). LABD carries a Unified Composite Score of 51.2/100 (HOLD) at $8.09 (N/M Forward P/E, N/A operating margin), whereas YANG carries 44.0/100 (HOLD) at $33.71 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While LABD currently prints a higher short-term Unified Composite Score (51.2/100 HOLD vs. YANG 44.0/100 HOLD), YANG captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LABD vs YANG. Trailing 12-month operating profitability (LABD N/A vs YANG N/A) and valuation multiples (LABD N/M vs YANG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
YANG Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ LABD vs YANG Key Questions & Quantitative Answers
As of Nov 16, 2026, Direxion Daily FTSE China Bear 3X Shares (YANG) is the stronger overall head-to-head candidate over Direxion Daily S&P Biotech Bear 3X Shares (LABD) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). LABD carries a Unified Composite Score of 51.2/100 (HOLD) at $8.09 (N/M Forward P/E, N/A operating margin), whereas YANG carries 44.0/100 (HOLD) at $33.71 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While LABD currently prints a higher short-term Unified Composite Score (51.2/100 HOLD vs. YANG 44.0/100 HOLD), YANG captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
LABD and YANG split Growth & Scale metrics: LABD posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with YANG at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, LABD generates N/A in USD-normalized revenue versus N/A for YANG. In operating R&D and SG&A reinvestment, LABD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for YANG.
LABD and YANG trade at balanced relative valuation multiples. LABD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas YANG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LABD (N/A ROE) versus YANG (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, LABD carries 76.1% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-3.71β · 120% Vol realized risk). By comparison, YANG carries 60.0% implied volatility (46th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.37β · 60% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.